GSK-J4
-
- Application
- Inhibition (Inh)
- Purpose
- JMJ H3K27 Demethylase inhibitor (cell permeable)
- Characteristics
- Histone demethylase JMJD3/UTX inhibitor. Inhibits demethylation of histone H3K27. Reduces LPS-induced proinflammatory cytokine production in primary human macrophages (IC50 = 9 μM for the inhibition of TNFα release). Cell permeable, ethyl ester of GSK J1. Rescues newborn pups from embryonic lethality in BRAF knockin mice which recapitulate major features of RASopathies.
- Purity
- >98 %
- Chemical Name
- N-[2-(2-Pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-alanine ethyl ester
- Formula
- C24H27N5O2
- Permeability
- Cell-permeable
- Solubility
- Soluble in DMSO (up to 40 mg/ml) or in Ethanol (up to 40 mg/ml).
-
-
- Restrictions
- For Research Use only
-
- Format
- Wax
- Storage
- -20 °C
-
- Background
- Epigenetics,Posttranslational modification,Protein demethylase,Immunology,Inflammation,Cytokine,Chromatin
- Molecular Weight
- 417.48
- CAS-No
- 1373423-53-0
-